Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF

Dendritic cell (DC)-based vaccination is a promising strategy for cancer immunotherapy. However, clinical trials have indicated that immunosuppressive microenvironments induced by tumors profoundly suppress antitumor immunity and inhibit vaccine efficacy, resulting in insufficient reduction of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Song-Nan, Choi, Il-Kyu, Huang, Jing-Hua, Yoo, Ji-Young, Choi, Kyung-Ju, Yun, Chae-Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149171/
https://www.ncbi.nlm.nih.gov/pubmed/21468000
http://dx.doi.org/10.1038/mt.2011.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149171/
https://www.ncbi.nlm.nih.gov/pubmed/21468000
http://dx.doi.org/10.1038/mt.2011.29

Ejemplares similares